Presentation of data in report and SAS output [Regulatives / Guidelines]

posted by arl_stat – India, 2020-10-15 18:12 (1075 d 22:40 ago) – Posting: # 22010
Views: 1,711

Dear All,

Greetings !!

FDA recommends not to round off the decimal places for confidence intervals.
So for NTI drugs, the Swt, Swr and 95% upper bound and point estimate should be presented upto 2 decimal places without rounding off.

If for Cmax, the 95% upper bound value is 0.0025 and if presented as 0.00, will the study can be considered as pass?

For analysis in SAS, should we present the values in 2 decimals or 4 decimals without rounding off?

As in above criteria, if we present the data in 2 decimal places, the study is pass.

Please guide.

Thanks:-)

Complete thread:

UA Flag
Activity
 Admin contact
22,761 posts in 4,775 threads, 1,628 registered users;
37 visitors (0 registered, 37 guests [including 18 identified bots]).
Forum time: 16:52 CEST (Europe/Vienna)

Whenever a theory appears to you as the only possible one,
take this as a sign that you have neither understood the theory
nor the problem which it was intended to solve.    Karl R. Popper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5